Glooko conducted the study to examine remote patient monitoring uptake and diabetes-related outcomes during the COVID-19 pandemic for people with diabetes using a remote care solution.

Glooko conducted the study to determine if a comprehensive RPM diabetes management program was more effective in reducing HbA1c compared to usual care.

Cost and Outcomes of a Diabetes Remote Patient Monitoring System: A Simulation Analysis

Glooko And Cecelia Health’s Results Suggested Strong Patient Engagement And Clinically Meaningful Reductions In A1C And Above Average Time-In-Range.

Using secondary analyses to examine whether the comprehensive Glooko remote patient monitoring diabetes management program improved diabetes-related distress compared to usual care in a sample of adults with type 2 diabetes.